Literature DB >> 4029026

Treatment of severe infections with temocillin. Clinical and bacteriological evaluation.

B Schulze, H D Heilmann.   

Abstract

Included in a study of the clinical efficacy of temocillin were 20 hospitalised female patients suffering from infections of the respiratory or urinary tract, septicaemia or an abscess. Clinical evaluation revealed fully effective treatment in all patients, and all pathogens identified were eliminated during therapy with no adverse reactions being observed.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4029026     DOI： 10.2165/00003495-198500295-00046

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


  6 in total

1.  Temocillin, in-vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers.

Authors:  R M Brown; R Wise; J M Andrews
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

2.  In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.

Authors:  K Bartmann; R Tarbuc
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-12

3.  Temocillin in peripheral lymph.

Authors:  T Bergan; A Engeset; W Olszewski
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

4.  BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

Authors:  B Slocombe; M J Basker; P H Bentley; J P Clayton; M Cole; K R Comber; R A Dixon; R A Edmondson; D Jackson; D J Merrikin; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

5.  Antibacterial activity and beta-lactamase stability of temocillin.

Authors:  K Jules; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

6.  [Microbiological studies with the new penicillin BRL 17421 (temocillin)].

Authors:  R Malottke; J Potel
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553
  6 in total
  1 in total

Review 1.  Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.

Authors:  Tommaso Lupia; Ilaria De Benedetto; Giacomo Stroffolini; Stefano Di Bella; Simone Mornese Pinna; Verena Zerbato; Barbara Rizzello; Roberta Bosio; Nour Shbaklo; Silvia Corcione; Francesco Giuseppe De Rosa
Journal:  Antibiotics (Basel)       Date:  2022-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.